Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Trainline shares fell as much as 17%, the most in five years, after the UK competition watchdog opened an investigation into whether the rail-booking platform breached consumer law through “drip pricing.”
- Smith & Nephew shares drop to the lowest intraday level since May 12 after the medical devices maker said chief financial officer John Rogers will leave his position at the end of next month. Analysts suggest his departure will raise questions about the company’s outlook.
- Straumann drops as much as 9.1%, the most in a year, after the Swiss dental implant maker said Christopher Norbye would replace Guillaume Daniellot as CEO. Analysts at Bernstein and JPMorgan said Daniellot was “well-liked,” with the news overshadowing the better-than-expected earnings for the first half-year.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Carlsberg volume growth was softer than expected in the first half, as subdued beer demand in Europe and Asia undermined a strong performance in soft drinks.
- Shares in Frontline PLC which owns a fleet of large crude carriers are benefiting from elevated crude tanker rates due to uncertainty in the Strait of Hormuz.
- Smith & Nephew shares drop as much as 3.7% to the lowest intraday level since May 12 after the medical devices maker said chief financial officer John Rogers will leave his position at the end of next month. Analysts suggest his departure will raise questions about the company’s outlook.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Unitree Robotics shares opened 629% higher in their Shanghai trading debut after raising 6.1 billion yuan ($904 million) in an initial public offering that will make it the first publicly traded humanoid robot maker in mainland China.
- Baidu shares slumped as much as 14.4% in Hong Kong, putting it on track for its worst day since 2022, after the Chinese search-engine operator’s revenue missed estimates and AI capex soared.
- Xiaomi shares rise as much as 5% in Hong Kong after it reported smartphone revenue that was better than feared despite a global industry downturn. Its EV unit came under pressure from intense competition in China with Bernstein analysts saying management has lowered its full year EV sales target to 450,000 units.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Targa Resources (TRGP) shares rose as much as 9.8% to a record high after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046. Targa also announced a new 70-mile expansion of its planned Bull Run natural gas pipeline network in the Permian Basin region.
- Meta Platforms (META) is being sued by 29 states for allegedly deceiving the public by targeting children on Facebook and Instagram with technology designed to turn them into compulsive users and drive up advertising revenue. The states allege that Meta knowingly designed features that encouraged compulsive and prolonged use of its platforms by young people, while simultaneously misleading consumers about safety features on its platforms.
- Duolingo (DUOL) shares are up after D.A. Davidson upgraded the language learning platform to buy from neutral citing a “turning point” in acceleration of daily active user metrics.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Joe Deaux

- Amylyx Pharmaceuticals (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a “best-case scenario.”

- Targa Resources (TRGP) shares rose 6.9% after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046.

- Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations.
See omnystudio.com/listener for privacy information.